GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Sihuan Pharmaceutical Holdings Group Ltd (OTCPK:SHPHF) » Definitions » Total Assets

Sihuan Pharmaceutical Holdings Group (Sihuan Pharmaceutical Holdings Group) Total Assets : $1,615.6 Mil (As of Dec. 2023)


View and export this data going back to 2011. Start your Free Trial

What is Sihuan Pharmaceutical Holdings Group Total Assets?

Sihuan Pharmaceutical Holdings Group's Total Assets for the quarter that ended in Dec. 2023 was $1,615.6 Mil.

During the past 12 months, Sihuan Pharmaceutical Holdings Group's average Total Assets Growth Rate was -3.60% per year. During the past 3 years, the average Total Assets Growth Rate was -7.10% per year. During the past 5 years, the average Total Assets Growth Rate was -6.30% per year. During the past 10 years, the average Total Assets Growth Rate was -1.90% per year.

During the past 13 years, Sihuan Pharmaceutical Holdings Group's highest 3-Year average Total Assets Growth Rate was 130.90%. The lowest was -7.10%. And the median was 7.40%.

Total Assets is connected with ROA %. Sihuan Pharmaceutical Holdings Group's annualized ROA % for the quarter that ended in Dec. 2023 was -0.08%. Total Assets is also linked to Revenue through Asset Turnover. Sihuan Pharmaceutical Holdings Group's Asset Turnover for the quarter that ended in Dec. 2023 was 0.07.

Sihuan Pharmaceutical Holdings Group Total Assets Historical Data

The historical data trend for Sihuan Pharmaceutical Holdings Group's Total Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sihuan Pharmaceutical Holdings Group Total Assets Chart

Sihuan Pharmaceutical Holdings Group Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Total Assets
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1,792.41 1,994.70 2,275.86 1,741.41 1,615.56

Sihuan Pharmaceutical Holdings Group Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Total Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2,275.86 2,152.56 1,741.41 1,644.21 1,615.56

Sihuan Pharmaceutical Holdings Group Total Assets Calculation

Total Assets are all the assets a company owns.

From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.

Sihuan Pharmaceutical Holdings Group's Total Assets for the fiscal year that ended in Dec. 2023 is calculated as

Total Assets=Total Equity (A: Dec. 2023 )+Total Liabilities (A: Dec. 2023 )
=719.451+896.11
=1,615.6

Sihuan Pharmaceutical Holdings Group's Total Assets for the quarter that ended in Dec. 2023 is calculated as

Total Assets=Total Equity (Q: Dec. 2023 )+Total Liabilities (Q: Dec. 2023 )
=719.451+896.11
=1,615.6

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sihuan Pharmaceutical Holdings Group  (OTCPK:SHPHF) Total Assets Explanation

Total Assets is connected with ROA %.

Sihuan Pharmaceutical Holdings Group's annualized ROA % for the quarter that ended in Dec. 2023 is

ROA %=Net Income (Q: Dec. 2023 )/( (Total Assets (Q: Jun. 2023 )+Total Assets (Q: Dec. 2023 ))/ count )
=-1.224/( (1644.208+1615.561)/ 2 )
=-1.224/1629.8845
=-0.08 %

Note: The Net Income data used here is two times the semi-annual (Dec. 2023) data.

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Total Assets is linked to total revenue through Asset Turnover.

Sihuan Pharmaceutical Holdings Group's Asset Turnover for the quarter that ended in Dec. 2023 is

Asset Turnover
=Revenue (Q: Dec. 2023 )/( (Total Assets (Q: Jun. 2023 )+Total Assets (Q: Dec. 2023 ))/ count )
=112.719/( (1644.208+1615.561)/ 2 )
=112.719/1629.8845
=0.07

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.

Sihuan Pharmaceutical Holdings Group Total Assets Related Terms

Thank you for viewing the detailed overview of Sihuan Pharmaceutical Holdings Group's Total Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

Sihuan Pharmaceutical Holdings Group (Sihuan Pharmaceutical Holdings Group) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Sihuan Pharmaceutical Holdings Group Ltd (OTCPK:SHPHF) » Definitions » Total Assets
Comparable Companies
HKSE:01681 HKSE:01349 HKSE:02877 HKSE:06896 HKSE:03613 HKSE:02348 HKSE:01558 HKSE:01061 HKSE:02552 HKSE:02633 XTER:MRK ZTS NSE:SUNPHARMA TSE:4502 LSE:HLN XTAE:TEVA XSWX:SDZ NBIX SZSE:000538 NSE:DIVISLAB
Traded in Other Exchanges
00460:Hong Kong
Address
Zhubang 2000 Business Centre, 22nd Floor, Building 4, West Balizhuang, Chaoyang District, Beijing, CHN, 100025
Website
https://www.sihuanpharm.com
Sihuan Pharmaceutical Holdings Group Ltd is an investment holding company. Along with its subsidiaries, the company is engaged in the research & development and the manufacture & sale of pharmaceutical products. Its portfolio comprises products for diseases related to the cardio-cerebral vascular (CCV) system, Digestive System, Anti-Infective, metabolism, Respiratory, Neurology, and Others. The group has three reportable segments: the medical aesthetic products segment including the filling, shaping, supporting, supplementing, optoelectronic device, body sculpturing, skincare, and others to provide non- or minimally invasive medical aesthetics comprehensive solutions; the innovative medicine and other medicine segments; and the generic medicine segment.